ESR1 and neoplasm: However, although the mean and median LOX expression levels in ER negative tumours were lower than in ER positive tumours, there was a distinct subgroup of ∼14% (8/58) ER negative patients whose LOX expression levels were considerably higher than in all other ER negative tumours.